JP Morgan Chase’s PMV Pharmaceuticals PMVP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$261 Hold
214
﹤0.01% 7233
2025
Q4
$268 Sell
214
-700
-77% -$938 ﹤0.01% 7132
2025
Q3
$1.28K Hold
914
﹤0.01% 6963
2025
Q2
$969 Sell
914
-10,535
-92% -$10.3K ﹤0.01% 6626
2025
Q1
$12.5K Sell
11,449
-13,142
-53% -$17.8K ﹤0.01% 6254
2024
Q4
$37.1K Buy
24,591
+23,559
+2,283% +$37.3K ﹤0.01% 6109
2024
Q3
$1.54K Sell
1,032
-199,513
-99% -$308K ﹤0.01% 6664
2024
Q2
$325K Buy
200,545
+81,276
+68% +$147K ﹤0.01% 4907
2024
Q1
$203K Sell
119,269
-3,811,071
-97% -$7.12M ﹤0.01% 5346
2023
Q4
$12.2M Sell
3,930,340
-103,381
-3% -$274K ﹤0.01% 2273
2023
Q3
$24.8M Sell
4,033,721
-41,783
-1% -$287K ﹤0.01% 1523
2023
Q2
$25.5M Buy
4,075,504
+72,620
+2% +$381K ﹤0.01% 1526
2023
Q1
$19.1M Sell
4,002,884
-93,667
-2% -$659K ﹤0.01% 1699
2022
Q4
$35.6M Sell
4,096,551
-609,548
-13% -$6.5M ﹤0.01% 1286
2022
Q3
$56M Sell
4,706,099
-213,224
-4% -$3.08M 0.01% 993
2022
Q2
$70.1M Buy
4,919,323
+1,713,836
+53% +$24.9M 0.01% 895
2022
Q1
$66.7M Buy
3,205,487
+38,265
+1% +$675K 0.01% 1021
2021
Q4
$73.2M Buy
3,167,222
+1,360,130
+75% +$32.9M 0.01% 1022
2021
Q3
$53.9M Buy
1,807,092
+164,028
+10% +$5.24M 0.01% 1142
2021
Q2
$56.1M Buy
1,643,064
+707,674
+76% +$23.6M 0.01% 1164
2021
Q1
$30.8M Buy
935,390
+898,291
+2,421% +$35.4M ﹤0.01% 1430
2020
Q4
$2.28M Buy
37,099
+27,099
+271% +$1.06M ﹤0.01% 3385
2020
Q3
$380K Buy
+10,000
New +$368K ﹤0.01% 4103

Other funds holding PMVP